About Us

Crescent Diagnostics has developed an osteoporosis screening tool called BQT® (Bone Quality Test). BQT®, which will be launched under the brand name Osentia® in the UK and the Republic of Ireland in Q1 2014, is a patented screening test which identifies an individual’s risk of developing osteoporosis..

+ Learn More


  • 10 March 2014 … Crescent Diagnostics Ltd (“Crescent”) has launched Osentia®, a new convenient screening... more
  • 9 September 2013 … Crescent Diagnostics Ltd (“Crescent”), a developer of novel tests for predicting... more